COCP Cocrystal Pharma, Inc. - Common Stock
NASDAQ · Pharmaceuticals · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 13, 2026
$1.15
· % 处于52周区间
· 高于低点
· 至高点
$0.7652周低点
$2.0352周高点
市值 (MRQ)
$16M
P/E
-1.5
EPS
$-0.78
COCP 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$1.15
市值 (MRQ)
$16M
P/E
-1.5
EPS
$-0.78
ROE
-151.4%
52周区间
$1–$2
COCP 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
股票拆分
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 2022年10月11日 | 1-for-12 | 反向 |
| 2018年1月24日 | 1-for-30 | 反向 |
10年表现 收入、净利润、利润率和每股收益趋势
收入·2019-12-31 → 2020-12-31
EPS$-0.782016-12-31 → 2025-12-31
自由现金流$-8M2018-12-31 → 2025-12-31
净利率·2018-12-31 → 2020-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | COCP | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E | -1.55年均值 ≈-0.9 | ≈-0.9 | · | · | |
| P/S | 7.95年均值 ≈101.5 | ≈101.5 | · | · | |
| 市净率 (MRQ) | 15.15年均值 ≈3.6 | ≈3.6 | 2.6 | 估值过高 | |
| Price / FCF (股价/自由现金流) | -1.95年均值 ≈-15.8 | ≈-15.8 | · | · | |
| Price / Cash Flow (市现率) | -1.95年均值 ≈-15.9 | ≈-15.9 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 2.55年均值 ≈3.7 | ≈3.7 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | COCP | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| ROA | -76.2%5年均值 ≈-60.1% | ≈-60.1% | -12.4% | 弱 | |
| ROE | -151.4%5年均值 ≈-103.4% | ≈-103.4% | -57.6% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | COCP | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 1.25年均值 ≈20.0 | ≈20.0 | 2.3 | 低流动性 | |
| Quick Ratio (速动比率) | 3.25年均值 ≈19.0 | ≈19.0 | 1.1 | 低流动性 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
此比率组尚无数据
基本面数据不足，尚无法计算此比率组。
资本效率 资产周转率、库存周转率、应收账款周转率
此比率组尚无数据
基本面数据不足，尚无法计算此比率组。
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
14.2%
下次报告
十一月 12, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 13, 2026 | $-0.23 | $-0.17 | -36.7% |
| 2026年3月31日 | 五月 15, 2026 | $-0.17 | $-0.15 | -11.1% |
| 2025年12月31日 | $-0.17 | $-0.18 | 4.8% | |
| 2025年9月30日 | $-0.19 | $-0.21 | 11.3% | |
| 2025年6月30日 | $-0.20 | $-0.31 | 34.6% | |
| 2025年3月31日 | $-0.23 | $-0.52 | 55.3% | |
| 2024年12月31日 | $-0.32 | $-0.54 | 40.8% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $2M | $7M | · | · | · | · | · | |
| R&D Expense | $5M | $13M | $15M | $12M | $9M | $6M | $4M | $5M | $6M | $102M | $47M | $4M | |
| SG&A Expense | $4M | $5M | $6M | $6M | $5M | $6M | $5M | $4M | $2M | $4M | $7M | $2M | |
| Operating Expenses | $9M | $18M | $19M | $39M | $14M | $12M | $55M | $63M | $8M | $106M | $54M | $6M | |
| Operating Income | $-9M | $-18M | $-19M | $-39M | $-14M | $-10M | $-48M | $-63M | $-8M | $-106M | $-54M | $-6M | |
| Interest Expense | · | · | $-640.0K | $2.0K | $4.0K | $8.0K | $19.0K | $58.0K | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | · | · | $-7.0K | $126.0K | $180.0K | $96.0K | |
| Other Non-op | $188.0K | $374.0K | $575.0K | $-8.0K | $36.0K | $-62.0K | $237.0K | $294.0K | $769.0K | $2M | $-11M | $6M | |
| Pretax Income | $-9M | $-19M | · | · | · | $-10M | $-48M | $-63M | $-7M | $-104M | $-65M | $-151.0K | |
| Income Tax | · | · | · | · | · | · | · | $-14M | $-7M | $-29M | $-15M | $-52.0K | |
| Net Income | $-9M | $-18M | $-18M | $-39M | $-14M | $-10M | $-48M | $-49M | $-613.0K | $-75M | $-50M | $-99.0K | |
| EPS (Basic) | $-0.78 | $-1.72 | $-1.87 | $-4.77 | $-0.16 | · | · | · | $-0.03 | $-3.18 | $-2.40 | $0.00 | |
| EPS (Diluted) | $-0.78 | $-1.72 | $-1.87 | $-4.77 | · | · | · | · | $-0.03 | $-3.30 | $-2.40 | $-0.01 | |
| Shares (Basic) | 11,290,000 | 10,174,000 | 9,651,000 | 8,143,000 | 7,364,000 | · | 31,859 | 28,009 | 24,126,000 | 23,518,000 | 21,011,000 | 326,779,000 | |
| Shares (Diluted) | 11,290,000 | 10,174,000 | 9,651,000 | 8,143,000 | · | · | · | · | 24,126,000 | 23,533,000 | 21,011,000 | 327,753,000 | |
| EBITDA | $-9M | $-18M | · | $-39M | $-14M | $-10M | $-48M | $-63M | · | · | · | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $10M | $26M | $37M | $59M | $33M | $7M | $3M | $748.0K | $4M | $9M | $4M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $2M | |
| Receivables | · | · | · | · | · | $556.0K | $644.0K | · | $1.0K | $21.0K | $32.0K | $122.0K | |
| Prepaid Expense | $328.0K | $430.0K | $2M | $2M | $568.0K | $399.0K | $169.0K | $191.0K | $105.0K | $517.0K | $441.0K | $144.0K | |
| Current Assets | $8M | $12M | $29M | $40M | $59M | $34M | $8M | $3M | $2M | $5M | $10M | $6M | |
| PP&E (Net) | $93.0K | $153.0K | $271.0K | $342.0K | $453.0K | $591.0K | $431.0K | $384.0K | $119.0K | $280.0K | $430.0K | $284.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $983.0K | $1M | $1M | $1M | $949.0K | |
| Goodwill | · | · | · | · | $19M | $19M | $19M | $65M | $65M | $65M | $65M | $65M | |
| Total Assets | $10M | $13M | $31M | $41M | $79M | $54M | $29M | $69M | $121M | $125M | $224M | $259M | |
| Accounts Payable | $890.0K | $2M | $1M | $614.0K | $578.0K | $657.0K | $2M | $616.0K | $494.0K | $563.0K | · | $299.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | $563.0K | $3M | $693.0K | |
| Current Liabilities | $2M | $2M | $3M | $1M | $2M | $1M | $2M | $2M | $1M | $2M | $7M | $9M | |
| Capital Leases | $1M | $2M | $2M | $57.0K | $291.0K | $345.0K | $523.0K | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $14M | $20M | $50M | $65M | |
| Total Liabilities | $3M | $4M | $5M | $1M | $2M | $2M | $3M | $2M | $16M | $23M | $57M | $74M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | $50M | $65M | |
| Common Stock | $13.0K | $10.0K | $10.0K | $8.0K | $8.0K | $71.0K | $36.0K | $30.0K | $24.0K | $24.0K | $694.0K | $123.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | $243M | $240M | $229M | $19M | |
| Retained Earnings | $-342M | $-333M | $-316M | $-298M | $-259M | $-245M | $-235M | $-187M | $-138M | $-137M | $-63M | $-12M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | $0 | $236.0K | |
| Stockholders' Equity | $6M | $10M | $26M | $40M | $78M | $53M | $26M | $67M | $105M | $102M | $168M | $7M | |
| Liabilities + Equity | $10M | $13M | $31M | $41M | $79M | $54M | $29M | $69M | $121M | $125M | $224M | $259M | |
| Shares Outstanding | 13,784,000 | 10,174,000 | 10,174,000 | 8,143,000 | 8,143,000 | 70,439,000 | 35,150,000 | 29,938,000 | 24,275,000 | 23,801,000 | 694,396,000 | 122,494 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $72.0K | $126.0K | $189.0K | $185.0K | $190.0K | $157.0K | $98.0K | $6.0K | $101.0K | $201.0K | $192.0K | $199.0K | |
| Stock-based Comp | $270.0K | $643.0K | $801.0K | $855.0K | $724.0K | $662.0K | $351.0K | $562.0K | $614.0K | $548.0K | $3M | $38.0K | |
| Deferred Tax | · | · | · | · | · | · | $-14M | $-14M | $-7M | $-29M | $-15M | $-54.0K | |
| Operating Cash Flow | $-8M | $-16M | $-15M | $-21M | $-13M | $-10M | $-2M | $-8M | $-7M | $-15M | $-10M | $-6M | |
| CapEx | $12.0K | $8.0K | $118.0K | $74.0K | $52.0K | $240.0K | $145.0K | $28.0K | $40.0K | $51.0K | $339.0K | $5.0K | |
| Investing Cash Flow | $-12.0K | $-8.0K | $-118.0K | $-74.0K | $-52.0K | $-240.0K | $-145.0K | $1M | $-40.0K | $3.0K | $-262.0K | $6M | |
| Stock Issued | $154.0K | · | $4M | · | $39M | $36M | $7M | $8M | $3M | $9M | $16M | · | |
| Net Stock Activity | $154.0K | · | · | · | $39M | $36M | $7M | $8M | · | · | · | · | |
| Financing Cash Flow | $5M | · | $4M | $-27.0K | $38M | $36M | $6M | $9M | $4M | $9M | $16M | $3M | |
| Net Change in Cash | $-3M | $-16M | $-11M | $-22M | $26M | $26M | $5M | $2M | $-3M | $-6M | $5M | $3M | |
| Free Cash Flow | $-8M | $-16M | · | $-22M | $-13M | $-10M | $-2M | $-8M | · | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | $-8M | · | · | · | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -476.0% | -737.5% | 108489.7% | · | · | · | · | |
| Net Margin | · | · | · | · | · | -479.0% | -733.8% | 84565.5% | · | · | · | · | |
| Pretax Margin | · | · | · | · | · | -479.0% | -733.8% | 107982.8% | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | -476.0% | -737.5% | 108489.7% | · | · | · | · | |
| ROA | -76.2% | -78.3% | · | -64.6% | -21.2% | -23.3% | -99.2% | -51.6% | · | · | · | · | |
| ROE | -151.4% | -157.5% | · | -86.8% | -17.9% | -18.8% | -99.9% | -55.2% | · | · | · | · | |
| ROIC | · | · | · | · | · | · | · | -73.7% | · | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 4.8 | · | 33.0 | 38.4 | 25.0 | 3.6 | 1.9 | · | · | · | · | |
| Quick Ratio | 3.2 | 4.1 | · | 30.6 | 38.0 | 24.7 | 3.5 | 1.7 | · | · | · | · | |
| Interest Coverage | · | · | · | -19414.5 | -3555.2 | -1198.2 | · | -1084.9 | · | · | · | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | 0.1 | -0.0 | · | · | · | · | |
| Receivables Turnover | · | · | · | · | · | 3.4 | 20.4 | · | · | · | · | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.46 | $0.94 | · | $4.86 | $0.80 | $0.75 | $0.73 | $2.23 | · | · | · | · | |
| Cash Flow / Share | $-0.73 | $-1.62 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.51 | $0.97 | · | $4.57 | $0.60 | $0.47 | $0.21 | $0.09 | · | · | · | · | |
| EPS (TTM) | $-0.78 | $-1.72 | $-1.87 | $-4.77 | · | · | $-0.07 | $0.03 | $-0.03 | $-3.30 | $-2.40 | $-0.01 |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $2M | $2M | $2M | $2M | $7M | $78.0K | $78.0K | $78.0K | · | · | |
| Net Income TTM | $-9M | $-18M | $-18M | $-39M | $-14M | $-10M | $-48M | $-49M | $-613.0K | $-75M | $-50M | $-99.0K | |
| Market Cap | $14M | $21M | · | $16M | $760M | $1.15B | $211M | $1.29B | · | · | · | · | |
| P/E | -1.3 | -1.2 | -0.9 | -0.4 | · | · | -85.7 | 1440.0 | -2400.0 | -42.5 | -133.5 | -15120.0 | |
| P/S | 6.8 | 10.3 | · | 8.0 | 380.9 | 570.8 | 32.1 | 16581.0 | · | · | · | · | |
| P/B | 2.1 | 2.2 | · | 0.4 | 9.8 | 21.9 | 8.2 | 19.3 | · | · | · | · | |
| P / Tangible Book | 2.1 | 2.2 | 0.7 | 0.4 | 13.0 | 34.4 | · | · | · | · | · | · | |
| P / Cash Flow | -1.6 | -1.2 | · | -0.7 | -59.8 | -116.9 | -134.9 | -156.0 | · | · | · | · | |
| P / FCF | -1.6 | -1.2 | · | -0.7 | -59.5 | -114.2 | -123.5 | -155.5 | · | · | · | · | |
| Earnings Yield | -79.6% | -85.2% | -108.7% | -244.6% | · | · | -1.2% | 0.07% | -0.04% | -2.4% | -0.75% | -0.01% |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $105.0K | $225.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $2M | $1M | $2M | $954.0K | $1M | $1M | $2M | $3M | $4M | $3M | $4M | $4M | $3M | $4M | $3M | $4M | |
| SG&A Expense | $1M | $1M | $862.0K | $1M | $986.0K | $981.0K | $1M | $2M | $1M | $1M | $1M | $2M | $2M | $1M | $1M | $2M | |
| Operating Expenses | $3M | $3M | $2M | $2M | $2M | $2M | $3M | $5M | $5M | $4M | $5M | $4M | $4M | $5M | $5M | $6M | |
| Operating Income | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-5M | $-5M | $-4M | $-5M | $-4M | $-4M | $-5M | $-5M | $-6M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $-220.0K | · | $-320.0K | $-140.0K | · | $0 | $1.0K | |
| Other Non-op | $20.0K | $57.0K | $55.0K | $40.0K | $53.0K | $40.0K | $-36.0K | $103.0K | $105.0K | $202.0K | $202.0K | $278.0K | $173.0K | $-78.0K | $1.0K | $-6.0K | |
| Income Tax | $0 | $0 | · | · | · | · | · | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-5M | $-5M | $-4M | $-4M | $-4M | $-4M | $-5M | $-5M | $-6M | |
| EPS (Basic) | $-0.23 | $-0.17 | $-0.16 | $-0.19 | $-0.20 | $-0.23 | $-0.31 | $-0.49 | $-0.53 | $-0.39 | $-0.41 | $-0.41 | $-0.41 | $-0.64 | $-0.55 | $-0.70 | |
| EPS (Diluted) | $-0.23 | $-0.17 | $-0.16 | $-0.19 | $-0.20 | $-0.23 | $-0.31 | $-0.49 | $-0.53 | $-0.39 | $-0.41 | $-0.41 | $-0.41 | $-0.64 | $-0.54 | $-0.70 | |
| Shares (Basic) | 13,788,000 | 13,786,000 | · | 10,991,000 | 10,174,000 | 10,174,000 | · | 10,174,000 | 10,174,000 | 10,174,000 | · | 10,153,000 | 10,065,000 | 8,143,000 | · | 8,143,000 | |
| Shares (Diluted) | 13,788,000 | 13,786,000 | · | 10,991,000 | 10,174,000 | 10,174,000 | · | 10,174,000 | 10,174,000 | 10,174,000 | · | 10,153,000 | 10,065,000 | 8,143,000 | · | 8,143,000 | |
| EBITDA | $-3M | $-2M | · | $-2M | $-2M | $-2M | · | $-5M | $-5M | $-4M | · | $-4M | · | $-5M | · | $-6M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $5M | $7M | $8M | $5M | $7M | $10M | $13M | $18M | $22M | $26M | $30M | $32M | $34M | $37M | $42M | |
| Prepaid Expense | $256.0K | $418.0K | $328.0K | $465.0K | $282.0K | $385.0K | $430.0K | $509.0K | $365.0K | $2M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Current Assets | $3M | $6M | $8M | $9M | $7M | $9M | $12M | $14M | $20M | $24M | $29M | $32M | $36M | $37M | $40M | $45M | |
| PP&E (Net) | $69.0K | $81.0K | $93.0K | $106.0K | $107.0K | $127.0K | $153.0K | $181.0K | $211.0K | $244.0K | $271.0K | $252.0K | $305.0K | $338.0K | $342.0K | $378.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | · | $2M | $2M | |
| Total Assets | $5M | $7M | $10M | $10M | $9M | $11M | $13M | $16M | $22M | $27M | $31M | $33M | $36M | $38M | $41M | $46M | |
| Accounts Payable | $2M | $1M | $890.0K | $745.0K | $856.0K | $808.0K | $2M | $859.0K | $2M | $1M | $1M | $568.0K | $1M | $3M | $614.0K | $897.0K | |
| Current Liabilities | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $2M | $2M | $3M | $1M | $2M | |
| Capital Leases | $989.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | · | $10.0K | $27.0K | $57.0K | $119.0K | |
| Total Liabilities | $4M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $2M | $2M | $3M | $1M | $2M | |
| Common Stock | $13.0K | $13.0K | $13.0K | $13.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $8.0K | $8.0K | $8.0K | |
| Retained Earnings | $-348M | $-345M | $-342M | $-340M | $-338M | $-336M | $-333M | $-330M | $-325M | $-320M | $-316M | $-311M | $-307M | $-303M | $-298M | $-293M | |
| Stockholders' Equity | $1M | $4M | $6M | $8M | $5M | $7M | $10M | $13M | $17M | $23M | $26M | $31M | $35M | $35M | $40M | $44M | |
| Liabilities + Equity | $5M | $7M | $10M | $10M | $9M | $11M | $13M | $16M | $22M | $27M | $31M | $33M | $36M | $38M | $41M | $46M | |
| Shares Outstanding | 13,789,000 | 13,787,000 | 13,784,000 | 13,041,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 8,143,000 | 8,143,000 | 8,143,000 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12.0K | $12.0K | $13.0K | $13.0K | $21.0K | $25.0K | $28.0K | $30.0K | $33.0K | $35.0K | $40.0K | $53.0K | $47.0K | $49.0K | $48.0K | $47.0K | |
| Stock-based Comp | $92.0K | $84.0K | $56.0K | $48.0K | $84.0K | $82.0K | $85.0K | $253.0K | $148.0K | $157.0K | $158.0K | $173.0K | $179.0K | $291.0K | $159.0K | $216.0K | |
| Operating Cash Flow | $-3M | $-2M | $-2M | $-1M | $-2M | $-3M | $-3M | $-5M | $-4M | $-5M | $-3M | $-3M | $-6M | $-3M | $-5M | $-9M | |
| CapEx | · | · | $0 | · | · | · | $0 | $0 | $0 | $8.0K | $59.0K | $0 | $14.0K | $45.0K | $12.0K | · | |
| Investing Cash Flow | · | · | $0 | · | · | · | $0 | $0 | $0 | $-8.0K | $-59.0K | $0 | $-14.0K | $-45.0K | $-12.0K | · | |
| Stock Issued | · | · | $0 | · | · | · | · | · | · | · | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | · | · | $1M | · | · | · | · | · | · | · | $0 | $0 | $4M | $-7.0K | $-7.0K | $-7.0K | |
| Net Change in Cash | $-3M | $-2M | $-704.0K | $3M | $-2M | $-3M | $-3M | $-5M | $-4M | $-5M | $-3M | $-3M | $-2M | $-3M | $-5M | $-9M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | $-3M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3032.4% | -1047.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -3013.3% | -1021.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -3032.4% | -1047.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -48.1% | -25.4% | · | -15.4% | -13.7% | -12.4% | · | -20.2% | -18.5% | -12.3% | · | -10.6% | · | -9.2% | · | -8.9% | |
| ROE | -99.2% | -40.3% | · | -20.1% | -18.1% | -15.4% | · | -22.8% | -20.5% | -13.8% | · | -11.2% | · | -9.6% | · | -9.1% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 2.7 | · | 5.8 | 3.7 | 4.6 | · | 7.3 | 7.4 | 10.3 | · | 16.7 | · | 11.8 | · | 27.7 | |
| Quick Ratio | 0.8 | 2.1 | · | 5.1 | 2.6 | 3.6 | · | 6.7 | 6.8 | 9.2 | · | 15.5 | · | 10.8 | · | 26.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 18.9 | · | 13.9 | · | · | · | -5694.0 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.08 | $0.30 | · | $0.59 | $0.52 | $0.72 | · | $1.25 | $1.71 | $2.22 | · | $3.02 | · | $4.26 | · | $5.39 | |
| Revenue / Share | $0.01 | $0.02 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.17 | · | · | · | $-0.29 | · | · | · | $-0.44 | · | · | · | · | · | · | |
| Cash / Share | $0.16 | $0.34 | · | $0.59 | $0.47 | $0.68 | · | $1.28 | $1.78 | $2.15 | · | $2.92 | · | $4.17 | · | $5.16 | |
| EPS (TTM) | $-0.75 | $-0.72 | · | $-0.93 | $-1.23 | $-1.56 | · | $-1.82 | $-1.74 | $-1.62 | · | $-2.00 | $-2.29 | $-4.88 | · | · |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Net Income TTM | $-10M | $-9M | · | $-10M | $-13M | $-16M | · | $-19M | $-18M | $-17M | · | $-18M | $-20M | $-40M | · | $-38M | |
| Market Cap | $14M | $14M | · | $16M | $15M | $14M | · | $18M | $24M | $14M | · | $19M | · | $16M | · | $28M | |
| P/E | -1.4 | -1.4 | · | -1.3 | -1.2 | -0.9 | · | -1.0 | -1.3 | -0.9 | · | -0.9 | -1.0 | -0.4 | · | · | |
| P/S | · | · | · | 8.1 | 7.5 | 7.2 | · | 8.9 | 11.8 | 7.1 | · | 9.4 | · | 8.0 | · | 14.1 | |
| P/B | 13.9 | 3.4 | · | 2.1 | 2.8 | 2.0 | · | 1.4 | 1.4 | 0.6 | · | 0.6 | · | 0.5 | · | 0.6 | |
| P / Tangible Book | 13.9 | 3.4 | · | 2.1 | 2.8 | 2.0 | · | 1.4 | 1.4 | 0.6 | · | 0.6 | 0.7 | 0.5 | · | 0.6 | |
| P / Cash Flow | · | -6.0 | · | · | · | -4.9 | · | · | · | -3.2 | · | · | · | -5.2 | · | · | |
| Earnings Yield | -71.4% | -71.3% | · | -74.4% | -82.5% | -109.9% | · | -103.4% | -74.7% | -115.7% | · | -106.9% | -95.8% | -245.2% | · | · |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 净收入 | $-9M | $-18M | $-18M | $-39M | $-14M |
| 稀释后每股收益 (EPS) | $-0.78 | $-1.72 | $-1.87 | $-4.77 | · |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 3.7 | 4.8 | · | 33.0 | 38.4 |
| 速动比率 | 3.2 | 4.1 | · | 30.6 | 38.0 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-8M | $-16M | · | $-22M | $-13M |
机构持有人 (13F) 28 家申报者 · $1.4M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
28
持有价值
$1.4M
新仓位
6
已退出持仓
6
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 6 (+2 与上一季度对比) | 6 (+3 与上一季度对比) | 3 (-3 与上一季度对比) | 7 (+3 与上一季度对比) | +336K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $376139 | 358228 | 26.77% | 股份 |
| VANGUARD GROUP INC | $258444 | 263987 | 18.40% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $188609 | 179628 | 13.43% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $184148 | 175379 | 13.11% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $80034 | 76208 | 5.70% | 股份 |
| BlackRock, Inc. | $77433 | 73746 | 5.51% | 股份 |
| CITADEL ADVISORS LLC | $47374 | 45118 | 3.37% | 股份 |
| NEUBERGER BERMAN GROUP LLC | $33480 | 31886 | 2.38% | 股份 |
| XTX Topco Ltd | $30809 | 29342 | 2.19% | 股份 |
| JANE STREET GROUP, LLC | $27049 | 25761 | 1.93% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $25217 | 24016 | 1.80% | 股份 |
| STATE STREET CORP | $21570 | 20543 | 1.54% | 股份 |
| Parallel Advisors, LLC | $13197 | 12569 | 0.94% | 股份 |
| NORTHERN TRUST CORP | $12517 | 11921 | 0.89% | 股份 |
| Ground Swell Capital, LLC | $11290 | 10752 | 0.80% | 股份 |
| WELLS FARGO & COMPANY/MN | $6570 | 6257 | 0.47% | 股份 |
| UBS Group AG | $4340 | 4133 | 0.31% | 股份 |
| Tower Research Capital LLC (TRC) | $4183 | 3984 | 0.30% | 股份 |
| MORGAN STANLEY | $915 | 871 | 0.07% | 股份 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $858 | 817 | 0.06% | 股份 |
| Clean Yield Group | $439 | 418 | 0.03% | 股份 |
| NVWM, LLC | $88 | 84 | 0.01% | 股份 |
| BARCLAYS PLC | $44 | 42 | 0.00% | 股份 |
| SBI Securities Co., Ltd. | $35 | 33 | 0.00% | 股份 |
| HRT FINANCIAL LP | $21 | 20336 | 0.00% | 股份 |
| VIMA LLC | $18 | 17 | 0.00% | 股份 |
| ROYAL BANK OF CANADA | $0 | 9 | 0.00% | 股份 |
| Motiv8 Investments LLC | $0 | 42 | 0.00% | 股份 |
激进投资者及 5%+ 股东 4 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Phillip Frost, M.D., Frost Gamma Investments Trust ×6 申报 | 2026年8月7日 | 13.90% | 修订 | 被动投资 | SEC |
| OPKO HEALTH, INC., FROST PHILLIP MD ET AL, Frost Gamma Investments Trust, Rubin Steven D ×5 申报 | 2026年8月7日 | 29.60% | 初始申报 | 被动投资 | SEC |
| FiveT Investment Management Ltd, FiveT Capital AG | 2021年5月25日 | · | 初始申报 | · | SEC |
| Raymond F. Schinazi, Phillip Frost, M.D., Frost Gamma Investments Trust, Gary Wilcox, Roger Kornberg, Steven D. Rubin ×3 申报 | 2019年3月19日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 18 位内幕人士 · 9 位高管 · 9 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| James Sapirstein | Chief Executive Officer | 2026年6月3日 A | · | 0 | 0 | $0 |
| Sam Lee | President and Co-CEO | 2026年1月9日 A | 76355 | 0 | 0 | $0 |
| James Joseph Martin | Co-CEO and CFO | 2026年1月9日 A | 44167 | 0 | 0 | $0 |
| Gary Wilcox | Chief Executive Officer | 2020年6月22日 A | 16948605 | 0 | 0 | $0 |
| Jeffery A. Meckler | CHIEF EXECUTIVE OFFICER | 2016年3月15日 P | 657161 | 0 | 0 | $0 |
| Curtis Dale | INTERIM CFO | 2015年11月24日 A | · | 0 | 0 | $0 |
| Gerald A Mcguire | CHIEF FINANCIAL OFFICER | 2015年4月13日 A | · | 0 | 0 | $0 |
| Douglas L Mayers | CHIEF MEDICAL OFFICER | 2015年10月1日 A | · | 0 | 0 | $0 |
| Walt Addison Linscott | GENERAL COUNSEL AND SECRETARY | 2015年7月21日 A | · | 0 | 0 | $0 |
| Phillip Frost, M.D. | 董事 | 2026年8月5日 P | 1993551 | 11 | 0 | $300525 |
| Anthony J Japour | 董事 | 2026年1月9日 A | 14924 | 0 | 0 | $0 |
| Roger D. Kornberg | 董事 | 2026年1月9日 A | 28109 | 0 | 0 | $0 |
| Steven D Rubin | 董事 | 2026年1月9日 A | 2660242 | 0 | 0 | $0 |
| Richard C Pfenniger JR | 董事 | 2026年1月9日 A | 31400 | 0 | 0 | $0 |
| Fred Hassan | 董事 | 2026年1月9日 A | 1383009 | 0 | 0 | $0 |
| David S Block | 董事 | 2018年9月21日 A | 168696 | 0 | 0 | $0 |
| HSIAO JANE PH D | 董事 | 2018年9月21日 A | 3435294 | 0 | 0 | $0 |
| Raymond F Schinazi | 10% 所有者 | 2021年5月4日 S | 7674960 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 2 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
COCP 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 7 位分析师
买入
中位数目标
$9.00
+686.0%
2 28.6%
强烈买入
4 57.1%
买入
1 14.3%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
2 位分析师 · 2026-09-29平均目标 $9.00 +686.0%
← 低于所有目标
当前价格 $1.15
最低$8.00
平均值$9.00
最高$10.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 13, 2026 申报